Top Markets
Coin of the day
Virbac SA Virbac SA

Virbac SA

VIRP
Rang in aandelen #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Aandeelprijs
$393.80
Marktkapitalisatie
$3.30B
Verandering (1 dag)
0.15%
Verandering (1 jaar)
4.67%
Land
FR
Handel Virbac SA (VIRP)

Categorie

Winst voor Virbac SA (VIRP)
Winst in Dec 2025 TTM: $255.41M
Volgens de meest recente financiële verslagen van Virbac SA bedraagt de huidige winst van het bedrijf $255.41M. In 2023 behaalde het bedrijf een winst van $192.52M, een stijging ten opzichte van de winst van 2022, die $189.27M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Virbac SA van 2002 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $255.41M 17.86%
2024 $216.71M 12.56%
2023 $192.52M 1.72%
2022 $189.27M 10.86%
2021 $170.73M -19.12%
2020 $211.09M 141.63%
2019 $87.36M 83.84%
2018 $47.52M -3.41%
2017 $49.20M -11.53%
2016 $55.61M 250.68%
2015 $15.86M -86.85%
2014 $120.60M -7.42%
2013 $130.28M 3.46%
2012 $125.92M 16.49%
2011 $108.09M -6.13%
2010 $115.16M 42.50%
2009 $80.81M 15.08%
2008 $70.22M -0.38%
2007 $70.49M 41.66%
2006 $49.76M 37.75%
2005 $36.13M 5.39%
2004 $34.28M 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$31.12B 12,085.71%
US
$24.94B 9,664.60%
US
$5.98B 2,239.36%
US
$11.63B 4,453.42%
US
$15.78B 6,079.72%
CH